Overall , 21 % of patients achieved remission ( LSAS score 30 ) at the endpoint , and 27 % of patients assigned to sertraline plus clonazepam achieved remission compared with patients assigned to sertraline plus placebo ( 17 % ) or venlafaxine ( 19 % ) , but the differences did not reach significance .